RecallRadar

FDA Device recall Z-1377-2024

Baxter Peri-Guard Repair Patch (legacy product codes): a) PC0404NBIO, b) PC0608NBIO, c) PC0814NBIO, d) PC1016NBIO

On 2024-04-03 the FDA classified a Class II recall of Baxter Peri-Guard Repair Patch (legacy product codes): a) PC0404NBIO, b) PC0608NBIO, c) PC0814NBIO, d) PC1016NBIO by Baxter Healthcare, citing A new contraindication was added to the IFU which states that Peri-Guard Repair Patch should not be used in neurosurgery since the product endotoxin level may be higher than the a….

Read the official FDA Device notice

AgencyFDA Device
Recall numberZ-1377-2024
ClassificationClass II
Statusongoing
Initiated2024-02-28
Published2024-04-03
Last updated2026-09-13 11:57 UTC
CompanyBaxter Healthcare
DistributionCT, IL, PA, TX, VA

Product

Baxter Peri-Guard Repair Patch (legacy product codes): a) PC0404NBIO, b) PC0608NBIO, c) PC0814NBIO, d) PC1016NBIO

Reason

A new contraindication was added to the IFU which states that Peri-Guard Repair Patch should not be used in neurosurgery since the product endotoxin level may be higher than the allowable limit for cerebrospinal fluid-contacting devices and Supple Peri-Guard Repair Patch should not be used in neurosurgery since the product endotoxin level may be higher than the allowable limit for cerebrospinal fluid-contacting devices.

Identifiers

code_info
a) PC0404NBIO, UDI/DI 00085412530529; b) PC0608NBIO, UDI/DI 00085412530567; c) PC0814NBIO, UDI/DI 00085412530581; d)…a) PC0404NBIO, UDI/DI 00085412530529; b) PC0608NBIO, UDI/DI 00085412530567; c) PC0814NBIO, UDI/DI 00085412530581; d) PC1016NBIO, UDI/DI 00085412530604; ALL LOTS WITHIN EXPIRY

Status history

No status changes recorded since RecallRadar first saw this recall on 2026-09-13 11:57 UTC. Current status: ongoing.

Source

Official record: https://api.fda.gov/device/enforcement.json?search=recall_number:%22Z-1377-2024%22

RecallRadar indexes public recall notices from the FDA, USDA FSIS, and CPSC. The official agency notice is the authoritative source. Always confirm details at the linked source before acting.